Post-authorisation experience and reported adverse events following use of a virus-like particle chikungunya vaccine, United States and Germany, up to August 2025. [PDF]
Euro SurveillSimone B, Lienert F.
europepmc +1 more source
Post-market quality monitoring of medicines in Christian Health Association of Ghana health institutions. [PDF]
Ghana Med JArhinful DK +8 more
europepmc +1 more source
Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients. [PDF]
J Clin Exp HematopOkazuka K +5 more
europepmc +1 more source
FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma. [PDF]
Clin Cancer ResBritton K +6 more
europepmc +1 more source
Real-World Data on Severe Cutaneous Adverse Reactions to Drugs. [PDF]
Pharmaceuticals (Basel)Zyryanov S +5 more
europepmc +1 more source
A multicenter, postmarketing surveillance of elobixibat in patients with chronic constipation in Japan: A final analysis report. [PDF]
SAGE Open MedNakajima A +4 more
europepmc +1 more source
Dose Optimization in Oncology Drug Development: Risk Factors for Postmarketing Requirements and Commitments. [PDF]
Clin Pharmacol TherKitagaki H, Takeda K, Murai K, Maeda H.
europepmc +1 more source
Dose Determinations at Drug Approval Reviews: FDA-Approved Drugs in Past 5 Years. [PDF]
Clin Pharmacol TherMita S, Ono S.
europepmc +1 more source
Regulatory Impact of Selected U.S. FDA Postmarketing Safety Registries Conducted for Drugs Used to Treat Inflammatory or Autoimmune Conditions. [PDF]
Pharmacoepidemiol Drug SafGuiriansoro Z, Oussova T, Weissfeld J.
europepmc +1 more source